Search This Blog

Saturday, April 12, 2025

Enzymatic biofuel cell

From Wikipedia, the free encyclopedia

An enzymatic biofuel cell is a specific type of fuel cell that uses enzymes as a catalyst to oxidize its fuel, rather than precious metals. Enzymatic biofuel cells, while currently confined to research facilities, are widely prized for the promise they hold in terms of their relatively inexpensive components and fuels, as well as a potential power source for bionic implants.

Operation

A general diagram for an enzymatic biofuel cell using Glucose and Oxygen. The blue area indicates the electrolyte.

Enzymatic biofuel cells work on the same general principles as all fuel cells: use a catalyst to separate electrons from a parent molecule and force it to go around an electrolyte barrier through a wire to generate an electric current. What makes the enzymatic biofuel cell distinct from more conventional fuel cells are the catalysts they use and the fuels that they accept. Whereas most fuel cells use metals like platinum and nickel as catalysts, the enzymatic biofuel cell uses enzymes derived from living cells (although not within living cells; fuel cells that use whole cells to catalyze fuel are called microbial fuel cells). This offers a couple of advantages for enzymatic biofuel cells: Enzymes are relatively easy to mass-produce and so benefit from economies of scale, whereas precious metals must be mined and so have an inelastic supply. Enzymes are also specifically designed to process organic compounds such as sugars and alcohols, which are extremely common in nature. Most organic compounds cannot be used as fuel by fuel cells with metal catalysts because the carbon monoxide formed by the interaction of the carbon molecules with oxygen during the fuel cell's functioning will quickly “poison” the precious metals that the cell relies on, rendering it useless. Because sugars and other biofuels can be grown and harvested on a massive scale, the fuel for enzymatic biofuel cells is extremely cheap and can be found in nearly any part of the world, thus making it an extraordinarily attractive option from a logistics standpoint, and even more so for those concerned with the adoption of renewable energy sources.

Enzymatic biofuel cells also have operating requirements not shared by traditional fuel cells. What is most significant is that the enzymes that allow the fuel cell to operate must be “immobilized” near the anode and cathode in order to work properly; if not immobilized, the enzymes will diffuse into the cell's fuel and most of the liberated electrons will not reach the electrodes, compromising its effectiveness. Even with immobilization, a means must also be provided for electrons to be transferred to and from the electrodes. This can be done either directly from the enzyme to the electrode (“direct electron transfer”) or with the aid of other chemicals that transfer electrons from the enzyme to the electrode (“mediated electron transfer”). The former technique is possible only with certain types of enzymes whose activation sites are close to the enzyme's surface, but doing so presents fewer toxicity risks for fuel cells intended to be used inside the human body. Finally, completely processing the complex fuels used in enzymatic biofuel cells requires a series of different enzymes for each step of the ‘metabolism’ process; producing some of the required enzymes and maintaining them at the required levels can pose problems.

History

Early work with biofuel cells, which began in the early 20th century, was purely of the microbial variety. Research on using enzymes directly for oxidation in biofuel cells began in the early 1960s, with the first enzymatic biofuel cell being produced in 1964. This research began as a product of NASA's interest in finding ways to recycle human waste into usable energy on board spacecraft, as well as a component of the quest for an artificial heart, specifically as a power source that could be put directly into the human body. These two applications – use of animal or vegetable products as fuel and development of a power source that can be directly implanted into the human body without external refueling – remain the primary goals for developing these biofuel cells. Initial results, however, were disappointing. While the early cells did successfully produce electricity, there was difficulty in transporting the electrons liberated from the glucose fuel to the fuel cell's electrode and further difficulties in keeping the system stable enough to produce electricity at all due to the enzymes’ tendency to move away from where they needed to be in order for the fuel cell to function. These difficulties led to an abandonment by biofuel cell researchers of the enzyme-catalyst model for nearly three decades in favor of the more conventional metal catalysts (principally platinum), which are used in most fuel cells. Research on the subject did not begin again until the 1980s after it was realized that the metallic-catalyst method was not going to be able to deliver the qualities desired in a biofuel cell, and since then work on enzymatic biofuel cells has revolved around the resolution of the various problems that plagued earlier efforts at producing a successful enzymatic biofuel cell.

However, many of these problems were resolved in 1998. In that year, it was announced that researchers had managed to completely oxidize methanol using a series (or “cascade”) of enzymes in a biofuel cell. Previous to this time, the enzyme catalysts had failed to completely oxidize the cell's fuel, delivering far lower amounts of energy than what was expected given what was known about the energy capacity of the fuel. While methanol is now far less relevant in this field as a fuel, the demonstrated method of using a series of enzymes to completely oxidize the cell's fuel gave researchers a way forward, and much work is now devoted to using similar methods to achieve complete oxidation of more complicated compounds, such as glucose. In addition, and perhaps what is more important, 1998 was the year in which enzyme “immobilization” was successfully demonstrated, which increased the usable life of the methanol fuel cell from just eight hours to over a week. Immobilization also provided researchers with the ability to put earlier discoveries into practice, in particular the discovery of enzymes that can be used to directly transfer electrons from the enzyme to the electrode. This process had been understood since the 1980s but depended heavily on placing the enzyme as close to the electrode as possible, which meant that it was unusable until after immobilization techniques were devised. In addition, developers of enzymatic biofuel cells have applied some of the advances in nanotechnology to their designs, including the use of carbon nanotubes to immobilize enzymes directly. Other research has gone into exploiting some of the strengths of the enzymatic design to dramatically miniaturize the fuel cells, a process that must occur if these cells are ever to be used with implantable devices. One research team took advantage of the extreme selectivity of the enzymes to completely remove the barrier between anode and cathode, which is an absolute requirement in fuel cells not of the enzymatic type. This allowed the team to produce a fuel cell that produces 1.1 microwatts operating at over half a volt in a space of just 0.01 cubic millimeters.

While enzymatic biofuel cells are not currently in use outside of the laboratory, as the technology has advanced over the past decade non-academic organizations have shown an increasing amount of interest in practical applications for the devices. In 2007, Sony announced that it had developed an enzymatic biofuel cell that can be linked in sequence and used to power an mp3 player, and in 2010 an engineer employed by the US Army announced that the Defense Department was planning to conduct field trials of its own "bio-batteries" in the following year. In explaining their pursuit of the technology, both organizations emphasized the extraordinary abundance (and extraordinarily low expense) of fuel for these cells, a key advantage of the technology that is likely to become even more attractive if the price of portable energy sources goes up, or if they can be successfully integrated into electronic human implants.

Feasibility of enzymes as catalysts

With respect to fuel cells, enzymes have several advantages to their incorporation. An important enzymatic property to consider is the driving force or potential necessary for successful reaction catalysis. Many enzymes operate at potentials close to their substrates which is most suitable for fuel cell applications.

Furthermore, the protein matrix surrounding the active site provides many vital functions; selectivity for the substrate, internal electron coupling, acidic/basic properties and the ability to bind to other proteins (or the electrode). Enzymes are more stable in the absence of proteases, while heat resistant enzymes can be extracted from thermophilic organisms, thus offering a wider range of operational temperatures. Operating conditions is generally between 20-50 °C and pH 4.0 to 8.0.

A drawback with the use of enzymes is size; given the large size of enzymes, they yield a low current density per unit electrode area due to the limited space. Since it is not possible to reduce enzyme size, it has been argued that these types of cells will be lower in activity. One solution has been to use three-dimensional electrodes or immobilization on conducting carbon supports which provide high surface area. These electrodes are extended into three-dimensional space which greatly increases the surface area for enzymes to bind thus increasing the current.

Hydrogenase-based biofuel cells

As per the definition of biofuel cells, enzymes are used as electrocatalysts at both the cathode and anode. In hydrogenase-based biofuel cells, hydrogenases are present at the anode for H2 oxidation in which molecular hydrogen is split into electrons and protons. In the case of H2/O2 biofuel cells, the cathode is coated with oxidase enzymes which then convert the protons into water.

Hydrogenase as an energy source

In recent years, research on hydrogenases has grown significantly due to scientific and technological interest in hydrogen. The bidirectional or reversible reaction catalyzed by hydrogenase is a solution to the challenge in the development of technologies for the capture and storage of renewable energy as fuel with use on demand. This can be demonstrated through the chemical storage of electricity obtained from a renewable source (e.g. solar, wind, hydrothermal) as H2 during periods of low energy demands. When energy is desired, H2 can be oxidized to produce electricity which is very efficient.

The use of hydrogen in energy converting devices has gained interest due to being a clean energy carrier and potential transportation fuel.

Feasibility of hydrogenase as catalysts

In addition to the advantages previously mentioned associated with incorporating enzymes in fuel cells, hydrogenase is a very efficient catalyst for H2 consumption forming electrons and protons. Platinum is typically the catalyst for this reaction however, the activity of hydrogenases are comparable without the issue of catalyst poisoning by H2S and CO. In the case of H2/O2 fuel cells, there is no production of greenhouse gases where the product is water.

With regards to structural advantages, hydrogenase is highly selective for its substrate. The lack of need for a membrane simplifies the biofuel cell design to be small and compact, given that hydrogenase does not react with oxygen (an inhibitor) and the cathode enzymes (typically laccase) does not react with the fuel. The electrodes are preferably made from carbon which is abundant, renewable and can be modified in many ways or adsorb enzymes with high affinity. The hydrogenase is attached to a surface which also extends the lifetime of the enzyme.

Challenges

There are several difficulties to consider associated with the incorporation of hydrogenase in biofuel cells. These factors must be taken into account to produce an efficient fuel cell.

Enzyme immobilization

Since the hydrogenase-based biofuel cell hosts a redox reaction, hydrogenase must be immobilized on the electrode in such a way that it can exchange electrons directly with the electrode to facilitate the transfer of electrons. This proves to be a challenge in that the active site of hydrogenase is buried in the center of the enzyme where the FeS clusters are used as an electron relay to exchange electrons with its natural redox partner.

Possible solutions for greater efficiency of electron delivery include the immobilization of hydrogenase with the most exposed FeS cluster close enough to the electrode or the use of a redox mediator to carry out the electron transfer. Direct electron transfer is also possible through the adsorption of the enzyme on graphite electrodes or covalent attachment to the electrode. Another solution includes the entrapment of hydrogenase in a conductive polymer.

Enzyme size

Immediate comparison of the size of hydrogenase with standard inorganic molecular catalysts reveal that hydrogenase is very bulky. It is approximately 5 nm in diameter compared to 1-5 nm for Pt catalysts. This limits the possible electrode coverage by capping the maximum current density.

Since altering the size of hydrogenase is not a possibility, to increase the density of enzyme present on the electrode to maintain fuel cell activity, a porous electrode can be used instead of one that is planar. This increases the electroactive area allowing more enzyme to be loaded onto the electrode. An alternative is to form films with graphite particles adsorbed with hydrogenase inside a polymer matrix. The graphite particles then can collect and transport electrons to the electrode surface.

Oxidative damage

In a biofuel cell, hydrogenase is exposed to two oxidizing threats. O2 inactivates most hydrogenases with the exception of [NiFe] through diffusion of O2 to the active site followed by destructive modification of the active site. O2 is the fuel at the cathode and therefore must be physically separated or else the hydrogenase enzymes at the anode would be inactivated. Secondly, there is a positive potential imposed on hydrogenase at the anode by the enzyme on the cathode. This further enhances the inactivation of hydrogenase by O2 causing even [NiFe] which was previously O2-tolerant, to be affected.

To avoid inactivation by O2, a proton exchange membrane can be used to separate the anode and cathode compartments such that O2 is unable to diffuse to and destructively modify the active site of hydrogenase.

Applications

Entrapment of hydrogenase in polymers

There are many ways to adsorb hydrogenases onto carbon electrodes that have been modified with polymers. An example is a study done by Morozov et al. where they inserted NiFe hydrogenase into polypyrrole films and to provide proper contact to the electrode, there were redox mediators entrapped into the film. This was successful because the hydrogenase density was high in the films and the redox mediator helped to connect all enzyme molecules for catalysis which was about the same power output as hydrogenase in solution.

Immobilizing hydrogenase on carbon nanotubes

Carbon nanotubes can also be used for a support for hydrogenase on the electrode due to their ability to assemble in large porous and conductive networks. These hybrids have been prepared using [FeFe] and [NiFe] hydrogenases. The [NiFe] hydrogenase isolated from A. aeolicus (thermophilic bacteria) was able to oxidize H2 with direct electron transfer without a redox mediator with a 10-fold higher catalytic current with stationary CNT-coated electrodes than with bare electrodes.

Another way of coupling hydrogenase to the nanotubes was to covalently bind them to avoid a time delay. Hydrogenase isolated from D. gigas (jumbo squid) was coupled to multiwalled carbon nanotube (MWCNT) networks and produced a current ~30 times higher than the graphite-hydrogenase anode. A slight drawback to this method is that the ratio of hydrogenase covering the surface of the nanotube network leaves hydrogenase to cover only the scarce defective spots in the network. It is also found that some adsorption procedures tend to damage the enzymes whereas covalently coupling them stabilized the enzyme and allows it to remain stable for longer. The catalytic activity of hydrogenase-MWCNT electrodes provided stability for over a month whereas the hydrogenase-graphite electrodes only lasted about a week.

Hydrogenase-based biofuel cell applications

A fully enzymatic hydrogen fuel cell was constructed by the Armstrong group who used the cell to power a watch. The fuel cell consisted of a graphite anode with hydrogenase isolated from R. metallidurans and a graphite cathode modified with fungal laccase. The electrodes were placed in a single chamber with a mixture of 3% H2 gas in air and there was no membrane due to the tolerance of the hydrogenase to oxygen. The fuel cell produced a voltage of 950mV and generated 5.2 uW/cm2 of electricity. Although this system was very functional, it was still not at optimum output due to the low accessible H2 levels, the lower catalytic activity of the oxygen tolerant hydrogenases and the lower density of catalysts on the flat electrodes.

This system was then later improved by adding a MWCNT network to increase the electrode area.

Applications

Self-powered biosensors

The beginning concept of applying enzymatic biofuel cells for self-powered biosensing applications has been introduced since 2001. With continued efforts, several types of self-powered enzyme-based biosensors have been demonstrated. In 2016, the first example of stretchable textile-based biofuel cells, acting as wearable self-powered sensors, was described. The smart textile device utilized a lactate oxidase-based biofuel cell, allowing real-time monitoring of lactate in sweat for on-body applications.

Cancer prevention

From Wikipedia, the free encyclopedia

Cancer prevention is the practice of taking active measures to decrease the incidence of cancer and mortality. The practice of prevention depends on both individual efforts to improve lifestyle and seek preventive screening, and socioeconomic or public policy related to cancer prevention. Globalized cancer prevention is regarded as a critical objective due to its applicability to large populations, reducing long term effects of cancer by promoting proactive health practices and behaviors, and its perceived cost-effectiveness and viability for all socioeconomic classes.

The majority of cancer cases are due to the accumulation of environmental pollution being inherited as epigenetic damage and most of these environmental factors are controllable lifestyle choices. Greater than a reported 75% of cancer deaths could be prevented by avoiding risk factors including: tobacco, overweight / obesity, an insufficient diet, physical inactivity, alcohol, sexually transmitted infections, and air pollution. Not all environmental causes are controllable, such as naturally occurring background radiation, and other cases of cancer are caused through hereditary genetic disorders. Current genetic engineering techniques under development may serve as preventive measures in the future. Future preventive screening measures can be additionally improved by minimizing invasiveness and increasing specificity by taking individual biological makeup into account, also known as "population-based personalized cancer screening."

Death rate adjusted for age for malignant cancer per 100,000 inhabitants in 2004.

While anyone can get cancer, age is one of the biggest factors that increases the risk of cancer: 3 out of 4 cancers are found in people aged 55 or older.

Risk reduction

Dietary

Advertisement for a healthy diet to possibly reduce cancer risk

An average 35% of human cancer mortality is attributed to the diet of the individual. Studies have linked excessive consumption of red or processed meat to an increased risk of breast cancer, colon cancer, and pancreatic cancer, a phenomenon which could be due to the presence of carcinogens in meats cooked at high temperatures. More specifically, a higher risk of breast cancer also has seemed to be associated with a higher intake of meat, including both red and processed meats.

Dietary recommendations for reducing cancer risk typically include an emphasis on vegetables, fruit, whole grains, and fish, and an avoidance of processed and red meat (beef, pork, lamb), animal fats, and refined carbohydrates. The World Cancer Research Fund recommends a diet rich in fruits and vegetables to reduce the risk of cancer. A diet rich in foods of plant origin, including non-starchy fruits and vegetables, non-starchy roots and tubers, and whole grains, may have protective effects against cancer. Consumption of coffee is associated with a reduced risk of liver cancer and endometrial cancer. Substituting processed foods, such as biscuits, cakes or white bread – which are high in fat, sugars and refined starches – with a plant-based diet may reduce the risk of cancer. In some cases, plant-based diets have shown to be inversely associated with overall cancer risk.

While many dietary recommendations have been proposed to reduce the risk of cancer, the evidence to support them is not definitive. The primary dietary factors that increase risk are obesity and alcohol consumption; with a diet low in fruits and vegetables and high in red meat being implicated but not confirmed. A 2014 meta-analysis did not find a relationship between consuming fruits and vegetables and reduced cancer risk.

Physical activity

Research shows that regular physical activity may help to reduce cancer up to 30%, with up to 300 minutes per week of moderate to vigorous intensity of physical activity recommended.

Possible mechanisms by which physical activity may reduce cancer risk include lowering levels of estrogen and insulin, reducing inflammation, and strengthening the immune system.

Medication and supplements

In the general population, NSAIDs reduce the risk of colorectal cancer; however, due to the cardiovascular and gastrointestinal side effects, they cause overall harm when used to lower cancer risk. Aspirin has been found to reduce the risk of death from cancer by about 7%. COX-2 inhibitors may decrease the rate of polyp formation in people with familial adenomatous polyposis however are associated with the same adverse effects as NSAIDs. Daily use of tamoxifen or raloxifene has been demonstrated to reduce the risk of developing breast cancer in high-risk women. The benefit verses harm for 5-alpha-reductase inhibitor such as finasteride is not clear.

Vitamins have not been found to be effective at reducing cancer risk, although low blood levels of vitamin D are correlated with increased cancer risk. Whether this relationship is causal and vitamin D supplementation is protective is not determined. Beta-carotene supplementation has been found to increase lung cancer rates in those who are at high risk. Folic acid supplementation has not been found effective in preventing colon cancer and may increase colon polyps. A 2018 systematic review concluded that selenium has no beneficial effect in reducing the risk of cancer based on high quality evidence.

Avoidance of carcinogens

The United States National Toxicology Program (NTP) has identified the chemical substances listed below as known human carcinogens in the NTP's 15th Report on Carcinogens. Simply because a substance has been designated as a carcinogen, however, does not mean that the substance will necessarily cause cancer. Many factors influence whether a person exposed to a carcinogen will develop cancer, including the amount and duration of the exposure and the individual's genetic background.

Ingestion

Inhalation

Skin exposure

Recent Updates in Carcinogen Classification

Updated evaluations by the International Agency for Research on Cancer (IARC) continue to confirm the carcinogenicity of long-recognized agents such as asbestos and benzene, which are included above in the NTP 15th report on carcinogens, while also guiding the assessment of emerging substances in consumer products. A meta-analysis published in 2023 found that exposure to certain endocrine-disrupting chemicals, including p,p′-DDT (and its metabolite p,p′-DDE) and several polychlorinated biphenyl (PCB) variants, was associated with increased risk of breast cancer.

Vaccination

Anti-cancer vaccines can be preventive or be used as therapeutic treatment. All such vaccines incite adaptive immunity by enhancing cytotoxic T lymphocyte (CTL) recognition and activity against tumor-associated or tumor-specific antigens (TAA and TSAs).

Vaccines have been developed that prevent infection by some carcinogenic viruses. Human papillomavirus vaccine (Gardasil and Cervarix) decreases the risk of developing cervical cancer. The hepatitis B vaccine prevents infection with hepatitis B virus and thus decreases the risk of liver cancer. The administration of human papillomavirus and hepatitis B vaccinations is recommended when resources allow.

Some cancer vaccines are usually immunoglobulin-based and target antigens specific to cancer or abnormal human cells. These vaccines may be given to treat cancer during the progression of disease to boost the immune system's ability to recognize and attack cancer antigens as foreign entities. Antibodies for cancer cell vaccines may be taken from the patient's own body (autologous vaccine) or from another patient (allogeneic vaccine). Several autologous vaccines, such as Oncophage for kidney cancer and Vitespen for a variety of cancers, have either been released or are undergoing clinical trial. FDA-approved vaccines, such as Sipuleucel-T for metastasizing prostate cancer or Nivolumab for melanoma and lung cancer can act either by targeting over-expressed or mutated proteins or by temporarily inhibiting immune checkpoints to boost immune activity.

Screening

Screening procedures, commonly sought for more prevalent cancers, such as colon, breast, and cervical, have greatly improved in the past few decades from advances in biomarker identification and detection. Early detection of pancreatic cancer biomarkers was accomplished using a SERS-based immunoassay approach. A SERS-based multiplex protein biomarker detection platform in a microfluidic chip can be used to detect several protein biomarkers to predict the type of disease and critical biomarkers and increase the chance of diagnosis between diseases with similar biomarkers (e.g. pancreatic cancer, ovarian cancer, and pancreatitis).

To improve the chances of detecting cancer early, all eligible people should take advantage of cancer screening services. However, overall uptake of cancer screening among the general population is not widespread, especially among disadvantaged groups (e.g. those with low income, mental illnesses, or are from different ethnic groups) who face different barriers that lead to lower attendance rates.

Cervical cancer

Cervical cancer is usually screened through in vitro examination of the cells of the cervix (e.g. Pap smear), colposcopy, or direct inspection of the cervix (after application of dilute acetic acid), or testing for HPV, the oncogenic virus that is the necessary cause of cervical cancer. Screening is recommended for women over 21 years, initially women between 21 and 29 years old are encouraged to receive Pap smear screens every three years, and those over 29 every five years. For women older than the age of 65 and with no history of cervical cancer or abnormality, and with an appropriate precedence of negative Pap test results may cease regular screening.

Still, adherence to recommended screening plans depends on age and may be linked to "educational level, culture, psychosocial issues, and marital status," further emphasizing the importance of addressing these challenges in regards to cancer screening.

Colorectal cancer

Colorectal cancer is most often screened with the fecal occult blood test (FOBT). Variants of this test include guaiac-based FOBT (gFOBT), the fecal immunochemical test (FIT), and stool DNA testing (sDNA). Further testing includes flexible sigmoidoscopy (FS), total colonoscopy (TC), or computed tomography (CT) scans if a total colonoscopy is non-ideal. The recommended age at which to begin and continue screening is 50-75 years. However, this is highly dependent on medical history and exposure to risk factors for colorectal cancer. Effective screening has been shown to reduce the incidence of colorectal cancer by 33% and colorectal cancer mortality by 43%.

Breast cancer

The estimated number of new breast cancer cases in the US in 2018 is predicted to be more than 1.7 million, with more than six hundred thousand deaths. Factors such as breast size, reduced physical activity, obesity and overweight status, infertility and never having had children, hormone replacement therapy (HRT), and genetics are risk factors for breast cancer. Mammograms are widely used to screen for breast cancer, and are recommended for women 50–74 years of age by the US Preventive Services Task Force (USPSTF). However, the USPSTF does not recommend mammograms for women 40–49 years old due to the possibility of overdiagnosis.

Preventable causes of cancer

As of 2017, tobacco use, diet and nutrition, physical activity, obesity/overweight status, infectious agents, and chemical and physical carcinogens have been reported to be the leading areas where cancer prevention can be practiced through enacting positive lifestyle changes, getting appropriate regular screening, and getting vaccinated.

The development of many common cancers are incited by such risk factors. For example, consumption of tobacco and alcohol, a medical history of genital warts and STDs, immunosuppression, unprotected sex, and early age of first sexual intercourse and pregnancy all may serve as risk factors for cervical cancer. Obesity, red meat or processed meat consumption, tobacco and alcohol, and a medical history of inflammatory bowel diseases are all risk factors for colorectal cancer (CRC). On the other hand, exercise and consumption of vegetables may help decrease the risk of CRC.

Several preventable causes of cancer were highlighted in Doll and Peto's landmark 1981 study, estimating that 75 – 80% of cancers in the United States could be prevented by avoidance of 11 different factors. A 2013 review of more recent cancer prevention literature by Schottenfeld et al., summarizing studies reported between 2000 and 2010, points to most of the same avoidable factors identified by Doll and Peto. However, Schottenfeld et al. considered fewer factors (e.g. non inclusion of diet) in their review than Doll and Peto, and indicated that avoidance of these fewer factors would result in prevention of 60% of cancer deaths. The table below indicates the proportions of cancer deaths attributed to different factors, summarizing the observations of Doll and Peto, Shottenfeld et al. and several other authors, and shows the influence of major lifestyle factors on the prevention of cancer, such as tobacco, an unhealthy diet, obesity and infections.

Proportions of cancer deaths in the United States attributed to different factors
Factor Doll &
Peto
Schottenfeld
et al.
Other reports
Tobacco 30% 30% 38% men, 23% women, 30%, 25-30%
Unhealthy diet 35% - 32%, 10%, 30-35%
Obesity * 10% 14% women, 20% men, among non-smokers, 10-20%, 19-20% United States, 16-18% Great Britain, 13% Brazil, 11-12% China
Infection 10% 5-8% 7-10%, 8% developed nations, 26% developing nations, 10% high income, 25% African
Alcohol 3% 3-4% 3.6%, 8% USA, 20% France
Occupational exposures 4% 3-5% 2-10%, may be 15-20% in men
Radiation (solar and ionizing) 3% 3-4% up to 10%
Physical inactivity * <5% 7%
Reproductive and sexual behavior 1-13% - -
Pollution 2% - -
Medicines and medical procedures 1% - -
Industrial products <1% - -
Food additives <1% - -

*Included in diet

†Carcinogenic infections include: for the uterine cervix (human papillomavirus [HPV]), liver (hepatitis B virus [HBV] and hepatitis C virus [HCV]), stomach (Helicobacter pylori [H pylori]), lymphoid tissues (Epstein-Barr virus [EBV]), nasopharynx (EBV), urinary bladder (Schistosoma hematobium), and biliary tract (Opisthorchis viverrini, Clonorchis sinensis)

History of cancer prevention

Cancer has been thought to be a preventable disease since the time of Roman physician Galen, who observed that an unhealthy diet was correlated with cancer incidence. In 1713, Italian physician Ramazzini hypothesized that abstinence caused lower rates of cervical cancer in nuns. Further observation in the 18th century led to the discovery that certain chemicals, such as tobacco, soot and tar (leading to scrotal cancer in chimney sweeps, as reported by Percivall Pott in 1775), could serve as carcinogens for humans. Although Pott suggested preventive measures for chimney sweeps (wearing clothes to prevent contact bodily contact with soot), his suggestions were only put into practice in Holland, resulting in decreasing rates of scrotal cancer in chimney sweeps. Later, the 19th century brought on the onset of the classification of chemical carcinogens.

In the early 20th century, physical and biological carcinogens, such as X-ray radiation or the Rous Sarcoma Virus discovered 1911, were identified. Despite observed correlation of environmental or chemical factors with cancer development, there was a deficit of formal prevention research and lifestyle changes for cancer prevention were not feasible during this time.

In Europe, in 1987 the European Commission launched the European Code Against Cancer to help educate the public about actions they can take to reduce their risk of getting cancer. The first version of the code covered 10 recommendations covering tobacco, alcohol, diet, weight, sun exposure, exposure to known carcinogens, early detection and participation in organized breast and cervical cancer screening programs. In the early 1990s, the European School of Oncology led a review of the code and added details about the scientific evidence behind each of the recommendations. Later updates were coordinated by the International Agency for Research on Cancer. The fourth edition of the code, developed in 2012‒2013, also includes recommendations on participation in vaccination programs for hepatitis B (infants) and human papillomavirus (girls), breast feeding and hormone replacement therapy, and participation in organized colorectal cancer screening programs.

Digestive enzyme

From Wikipedia, the free encyclopedia
https://en.wikipedia.org/wiki/Digestive_enzyme
Diagram of the digestive enzymes in the small intestine and pancreas

Digestive enzymes take part in the chemical process of digestion, which follows the mechanical process of digestion. Food consists of macromolecules of proteins, carbohydrates, and fats that need to be broken down chemically by digestive enzymes in the mouth, stomach, pancreas, and duodenum, before being able to be absorbed into the bloodstream. Initial breakdown is achieved by chewing (mastication) and the use of digestive enzymes of saliva. Once in the stomach further mechanical churning takes place mixing the food with secreted gastric acid. Digestive gastric enzymes take part in some of the chemical process needed for absorption. Most of the enzymatic activity, and hence absorption takes place in the duodenum.

Digestive enzymes are found in the digestive tracts of animals (including humans) and in the tracts of carnivorous plants, where they aid in the digestion of food, as well as inside cells, especially in their lysosomes, where they function to maintain cellular survival.

Digestive enzymes are classified based on their target substrates: lipases split fatty acids into fats and oils; proteases and peptidases split proteins into small peptides and amino acids; amylases split carbohydrates such as starch and sugars into simple sugars such as glucose, and nucleases split nucleic acids into nucleotides.

Types

Table of the different major digestive enzymes

Digestive enzymes are found throughout much of the gastrointestinal tract. In the human digestive system, the main sites of digestion are the mouth, stomach, and small intestine. Digestive enzymes are secreted by different exocrine glands including salivary glands, gastric glands, secretory cells in the pancreas, and secretory glands in the small intestine. In some carnivorous plants plant-specific digestive enzymes are used to break down their captured organisms.

Mouth

Complex food substances that are eaten must be broken down into simple, soluble, and diffusible substances before they can be absorbed. In the oral cavity, salivary glands secrete an array of enzymes and substances that aid in digestion and also disinfection. They include the following:

  • Lingual lipase: Lipid digestion initiates in the mouth. Lingual lipase starts the digestion of the lipids/fats.
  • Salivary amylase: Carbohydrate digestion also initiates in the mouth. Amylase, produced by the salivary glands, breaks complex carbohydrates, mainly cooked starch, to smaller chains, or even simple sugars. It is sometimes referred to as ptyalin.
  • Lysozyme: Considering that food contains more than just essential nutrients, e.g. bacteria or viruses, the lysozyme offers a limited and non-specific, yet beneficial antiseptic function in digestion.

Of note is the diversity of the salivary glands. There are two types of salivary glands:

  • Serous glands: These glands produce a secretion rich in water, electrolytes, and enzymes. A great example of a serous oral gland is the parotid gland.
  • Mixed glands: These glands have both serous cells and mucous cells, and include sublingual and submandibular glands. Their secretion is mucinous and high in viscosity.

Stomach

The enzymes that are secreted in the stomach are gastric enzymes. The stomach plays a major role in digestion, both in a mechanical sense by mixing and crushing the food, and also in an enzymatic sense, by digesting it. The following are enzymes produced by the stomach and their respective function:

  • Pepsin is the main gastric enzyme. It is produced in the stomach by gastric chief cells in its inactive form pepsinogen, which is a zymogen. Pepsinogen is then activated by the stomach acid into its active form, pepsin. Pepsin breaks down the protein in the food into smaller particles, such as peptide fragments and amino acids. Protein digestion, therefore, primarily starts in the stomach, unlike carbohydrate and lipids, which start their digestion in the mouth (however, trace amounts of the enzyme kallikrein, which catabolises certain protein, is found in saliva in the mouth).
  • Gastric lipase: Gastric lipase is an acidic lipase secreted by the gastric chief cells in the fundic mucosa of the stomach. It has a pH level of 3–6. Gastric lipase, together with lingual lipase, comprise the two acidic lipases. These lipases, unlike alkaline lipases (such as pancreatic lipase), do not require bile acid or colipase for optimal enzymatic activity. Acidic lipases make up 30% of lipid hydrolysis occurring during digestion in the human adult, with gastric lipase contributing the most of the two acidic lipases. In neonates, acidic lipases are much more important, providing up to 50% of total lipolytic activity.
  • Cathepsin F: is a cysteine protease.

Pancreas

The pancreas is both an endocrine, and an exocrine gland, in that it functions to produce endocrinic hormones released into the circulatory system (such as insulin, and glucagon), to control glucose metabolism, and also to secrete digestive / exocrinic pancreatic juice, which is secreted eventually via the pancreatic duct into the duodenum. Digestive or exocrine function of pancreas is as significant to the maintenance of health as its endocrine function.

Two of the population of cells in the pancreatic tissue make up its digestive enzymes:

  • Ductal cells: Mainly responsible for production of bicarbonate (HCO3), which acts to neutralize the acidity of the stomach chyme entering duodenum through the pylorus. Ductal cells of the pancreas are stimulated by the hormone secretin to produce their bicarbonate-rich secretions, in what is in essence a bio-feedback mechanism; highly acidic stomach chyme entering the duodenum stimulates duodenal cells called "S cells" to produce the hormone secretin and release to the bloodstream. Secretin having entered the blood eventually comes into contact with the pancreatic ductal cells, stimulating them to produce their bicarbonate-rich juice. Secretin also inhibits production of gastrin by "G cells", and also stimulates acinar cells of the pancreas to produce their pancreatic enzyme.
  • Acinar cells: Mainly responsible for production of the inactive pancreatic enzymes (zymogens) that, once present in the small bowel, become activated and perform their major digestive functions by breaking down proteins, fat, and DNA/RNA. Acinar cells are stimulated by cholecystokinin (CCK), which is a hormone/neurotransmitter produced by the intestinal cells (I cells) in the duodenum. CCK stimulates production of the pancreatic zymogens.

Pancreatic juice, composed of the secretions of both ductal and acinar cells, contains the following digestive enzymes:

Some of the preceding endogenous enzymes have pharmaceutical counterparts (pancreatic enzymes) that are administered to people with exocrine pancreatic insufficiency.

The pancreas's exocrine function owes part of its notable reliability to biofeedback mechanisms controlling secretion of the juice. The following significant pancreatic biofeedback mechanisms are essential to the maintenance of pancreatic juice balance/production:

  • Secretin, a hormone produced by the duodenal "S cells" in response to the stomach chyme containing high hydrogen atom concentration (high acidity), is released into the blood stream; upon return to the digestive tract, secretion decreases gastric emptying, increases secretion of the pancreatic ductal cells, as well as stimulating pancreatic acinar cells to release their zymogenic juice.
  • Cholecystokinin (CCK) is a unique peptide released by the duodenal "I cells" in response to chyme containing high fat or protein content. Unlike secretin, which is an endocrine hormone, CCK actually works via stimulation of a neuronal circuit, the end-result of which is stimulation of the acinar cells to release their content. CCK also increases gallbladder contraction, resulting in bile squeezed into the cystic duct, common bile duct and eventually the duodenum. Bile of course helps absorption of the fat by emulsifying it, increasing its absorptive surface. Bile is made by the liver, but is stored in the gallbladder.
  • Gastric inhibitory peptide (GIP) is produced by the mucosal duodenal cells in response to chyme containing high amounts of carbohydrate, proteins, and fatty acids. Main function of GIP is to decrease gastric emptying.
  • Somatostatin is a hormone produced by the mucosal cells of the duodenum and also the "delta cells" of the pancreas. Somatostatin has a major inhibitory effect, including on pancreatic production.

Duodenum

The following enzymes/hormones are produced in the duodenum:

  • secretin: This is an endocrine hormone produced by the duodenal "S cells" in response to the acidity of the gastric chyme.
  • Cholecystokinin (CCK) is a unique peptide released by the duodenal "I cells" in response to chyme containing high fat or protein content. Unlike secretin, which is an endocrine hormone, CCK actually works via stimulation of a neuronal circuit, the end-result of which is stimulation of the acinar cells to release their content. CCK also increases gallbladder contraction, causing release of pre-stored bile into the cystic duct, and eventually into the common bile duct and via the ampulla of Vater into the second anatomic position of the duodenum. CCK also decreases the tone of the sphincter of Oddi, which is the sphincter that regulates flow through the ampulla of Vater. CCK also decreases gastric activity and decreases gastric emptying, thereby giving more time to the pancreatic juices to neutralize the acidity of the gastric chyme.
  • Gastric inhibitory peptide (GIP): This peptide decreases gastric motility and is produced by duodenal mucosal cells.
  • motilin: This substance increases gastro-intestinal motility via specialized receptors called "motilin receptors".
  • somatostatin: This hormone is produced by duodenal mucosa and also by the delta cells of the pancreas. Its main function is to inhibit a variety of secretory mechanisms.

Throughout the lining of the small intestine there are numerous brush border enzymes whose function is to further break down the chyme released from the stomach into absorbable particles. These enzymes are absorbed whilst peristalsis occurs. Some of these enzymes include:

  • Various exopeptidases and endopeptidases including dipeptidase and aminopeptidases that convert peptones and polypeptides into amino acids.
  • Maltase: converts maltose into glucose.
  • Lactase: This is a significant enzyme that converts lactose into glucose and galactose. A majority of Middle-Eastern and Asian populations lack this enzyme. This enzyme also decreases with age. As such lactose intolerance is often a common abdominal complaint in the Middle-Eastern, Asian, and older populations, manifesting with bloating, abdominal pain, and osmotic diarrhea.
  • Sucrase: converts sucrose into glucose and fructose.
  • Other disaccharidases

Plants

In carnivorous plants, digestive enzymes and acids break down insects and in some plants small animals. In some plants, the leaf collapses on the prey to increase contact, others have a small vessel of digestive liquid. Then digestion fluids are used to digest the prey to get at the needed nitrates and phosphorus. The absorption of the needed nutrients are usually more efficient than in other plants. Digestive enzymes independently came about in carnivorous plants and animals.

Some carnivorous plants like the Heliamphora do not use digestive enzymes, but use bacteria to break down the food. These plants do not have digestive juices, but use the rot of the prey.

Some carnivorous plants digestive enzymes:

Clinical significance

Alpha-glucosidase inhibitors and alpha amylase inhibitors are found in several raw plants such as cinnamon. They are used as anti-diabetic drugs. Studies have shown that the use of raw cinnamon offers potential anti-diabetic therapeutic use.

Political system

From Wikipedia, the free encyclopedia

In political science, a political system means the form of political organization that can be observed, recognised or otherwise declared by a society or state.

It defines the process for making official government decisions. It usually comprizes the governmental legal and economic system, social and cultural system, and other state and government specific systems. However, this is a very simplified view of a much more complex system of categories involving the questions of who should have authority and what the government influence on its people and economy should be.

Along with a basic sociological and socio-anthropological classification, political systems can be classified on a social-cultural axis relative to the liberal values prevalent in the Western world, where the spectrum is represented as a continuum between political systems recognized as democracies, totalitarian regimes and, sitting between these two, authoritarian regimes, with a variety of hybrid regimes; and monarchies may be also included as a standalone entity or as a hybrid system of the main three.

Definition

According to David Easton, "A political system can be designated as the interactions through which values are authoritatively allocated for a society". Political system refers broadly to the process by which laws are made and public resources allocated in society, and to the relationships among those involved in making these decisions.

Basic classification

Social anthropologists generally recognize several kinds of political systems, often differentiating between ones that they consider uncentralized and ones they consider centralized.

  • Uncentralized systems
    • Band society
      • Small family group, no larger than an extended family or clan; it has been defined as consisting of no more than 30 to 50 individuals.
      • A band can cease to exist if only a small group walks out.
    • Tribe
      • Generally larger, consisting of many families. Tribes have more social institutions, such as a chief or elders.
      • More permanent than bands. Many tribes are subdivided into bands.
  • Centralized governments
    • Chiefdom
      • More complex than a tribe or a band society, and less complex than a state or a civilization
      • Characterized by pervasive inequality and centralization of authority.
      • A single lineage/family of the elite class becomes the ruling elite of the chiefdom
      • Complex chiefdoms have two or even three tiers of political hierarchy.
      • "An autonomous political unit comprising a number of villages or communities under the permanent control of a paramount chief"
    • Sovereign state
      • A sovereign state is a state with a permanent population, a defined territory, a government and the capacity to enter into relations with other sovereign states.
  • Supranational political systems
    • Supranational political systems are created by independent nations to reach a common goal or gain strength from forming an alliance.
  • Empires
    • Empires are widespread states consisting of people of different ethnicities under a single rule. Empires - such as the Romans, or British - often made considerable progress in ways of political structures, creating and building city infrastructures, and maintaining civility within the diverse communities. Because of the intricate organization of the empires, they were often able to hold a large majority of power on a universal level.
  • Leagues
    • Leagues are international organizations composed of states coming together for a single common purpose. In this way, leagues are different from empires, as they only seek to fulfil a single goal. Often leagues are formed on the brink of a military or economic downfall. Meetings and hearings are conducted in a neutral location with representatives of all involved nations present.

Western socio-cultural paradigmatic-centric analysis

The sociological interest in political systems is figuring out who holds power within the relationship between the government and its people and how the government’s power is used. According to Yale professor Juan José Linz, there are three main types of political systems today: democracies, totalitarian regimes and, sitting between these two, authoritarian regimes (with hybrid regimes). Another modern classification system includes monarchies as a standalone entity or as a hybrid system of the main three. Scholars generally refer to a dictatorship as either a form of authoritarianism or totalitarianism.

Democracy

Democracy (from Ancient Greek: δημοκρατία, romanizeddēmokratía, dēmos 'people' and kratos 'rule') is a form of government in which political power is vested in the people or the population of a state. Under a minimalist definition of democracy, rulers are elected through competitive elections while more expansive or maximalist definitions link democracy to guarantees of civil liberties and human rights in addition to competitive elections.

Authoritarianism

Authoritarianism is a political system characterized by the rejection of political plurality, the use of strong central power to preserve the political status quo, and reductions in democracy, separation of powers, civil liberties, and the rule of law. Authoritarian regimes may be either autocratic or oligarchic and may be based upon the rule of a party or the military. States that have a blurred boundary between democracy and authoritarianism have some times been characterized as "hybrid democracies", "hybrid regimes" or "competitive authoritarian" states.

Totalitarian

Totalitarianism is a political system and a form of government that prohibits opposition from political parties, disregards and outlaws the political claims of individual and group opposition to the state, and completely controls the public sphere and the private sphere of society. In the field of political science, totalitarianism is the extreme form of authoritarianism, wherein all socio-political power is held by a dictator. This figure controls the national politics and peoples of the nation with continual propaganda campaigns that are broadcast by state-controlled and state-aligned private mass communications media.

Monarchy

A monarchy is a form of government in which a person, the monarch, reigns as head of state for rest of the life or until abdication. The extent of the authority of the monarch may vary from restricted and largely symbolic (constitutional monarchy), to fully autocratic (absolute monarchy), and may have representational, executive, legislative, and judicial functions.

The succession of monarchs has mostly been hereditary, often building dynasties; however, monarchies can also be elective and self-proclaimed. Aristocrats, though not inherent to monarchies, often function as the pool of persons from which the monarch is chosen, and to fill the constituting institutions (e.g. diet and court), giving many monarchies oligarchic elements. The political legitimacy of the inherited, elected or proclaimed monarchy has most often been based on claims of representation of people and land through some form of relation (e.g. kinship) and divine right or other achieved status.

Hybrid

A hybrid regime[a] is a type of political system often created as a result of an incomplete democratic transition from an authoritarian regime to a democratic one (or vice versa). Hybrid regimes are categorized as having a combination of autocratic features with democratic ones and can simultaneously hold political repressions and regular elections. Hybrid regimes are commonly found in developing countries with abundant natural resources such as petro-states. Although these regimes experience civil unrest, they may be relatively stable and tenacious for decades at a time. There has been a rise in hybrid regimes since the end of the Cold War.

The term hybrid regime arises from a polymorphic view of political regimes that oppose the dichotomy of autocracy or democracy. Modern scholarly analysis of hybrid regimes focuses attention on the decorative nature of democratic institutions (elections do not lead to a change of power, different media broadcast the government point of view and the opposition in parliament votes the same way as the ruling party, among others), from which it is concluded that democratic backsliding, a transition to authoritarianism is the most prevalent basis of hybrid regimes. Some scholars also contend that hybrid regimes may imitate a full dictatorship.

Marxist/Dialectical materialistic analysis

19th-century German-born philosopher Karl Marx analysed that the political systems of "all" state societies are the dictatorship of one social class, vying for its interests against that of another one; with which class oppressing which other class being, in essence, determined by the developmental level of that society, and its repercussions implicated thereof, as the society progresses through the passage of time. In capitalist societies, this characterises as the dictatorship of the bourgeoisie or capitalist class, in which the economic and political system is designed to work in their interests collectively as a class, over those of the proletariat or working class.

Marx devised this theory by adapting his forerunner-contemporary Georg Wilhelm Friedrich Hegel's notion of dialectics into the framework of materialism.

Human extinction

From Wikipedia, the free encyclopedia https://en.wikipedia.org/wiki/Human_ext...